Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries
- PMID: 19287299
- DOI: 10.1097/QAD.0b013e32832913ee
Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries
Abstract
Background: In developing countries, access to laboratory tests remains limited, and the use of simple tools such as weight to monitor HIV-infected patients treated with antiretroviral therapy should be evaluated.
Methods: Cohort study of 2451 Cambodian and 2618 Kenyan adults who initiated antiretroviral therapy between 2001 and 2007. The prognostic value of weight gain at 3 months of antiretroviral therapy on 3-6 months mortality, and at 6 months on 6-12 months mortality, was investigated using Poisson regression.
Results: Mortality rates [95% confidence interval (CI)] between 3 and 6 months of antiretroviral therapy were 9.9 (7.6-12.7) and 13.5 (11.0-16.7) per 100 person-years in Cambodia and Kenya, respectively. At 3 months, among patients with initial body mass index less than or equal to 18.5 kg/m (43% of the study population), mortality rate ratios (95% CI) were 6.3 (3.0-13.1) and 3.4 (1.4-8.3) for those with weight gain less than or equal to 5 and 5-10%, respectively, compared with those with weight gain of more than 10%. At 6 months, weight gain was also predictive of subsequent mortality: mortality rate ratio (95% CI) was 7.3 (4.0-13.3) for those with weight gain less than or equal to 5% compared with those with weight gain of more than 10%.
Conclusion: Weight gain at 3 months is strongly associated with survival. Poor compliance or undiagnosed opportunistic infections should be investigated in patients with initial body mass index less than or equal to 18.5 and achieving weight gain less than or equal to 10%.
Similar articles
-
Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.Clin Infect Dis. 2009 May 15;48(10):1459-66. doi: 10.1086/598335. Clin Infect Dis. 2009. PMID: 19348592
-
Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study.Clin Infect Dis. 2008 Nov 15;47(10):1345-53. doi: 10.1086/592692. Clin Infect Dis. 2008. PMID: 18834317
-
Efficacy of antiretroviral therapy program in children in India: prognostic factors and survival analysis.J Trop Pediatr. 2009 Aug;55(4):225-32. doi: 10.1093/tropej/fmm073. Epub 2008 Jun 3. J Trop Pediatr. 2009. PMID: 18522999
-
Effectiveness of highly active antiretroviral therapy in HIV-positive children: evaluation at 12 months in a routine program in Cambodia.Pediatrics. 2007 Nov;120(5):e1134-40. doi: 10.1542/peds.2006-3503. Epub 2007 Oct 22. Pediatrics. 2007. PMID: 17954553
-
Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia.AIDS. 2007 Jan 30;21(3):351-9. doi: 10.1097/QAD.0b013e328012c54f. AIDS. 2007. PMID: 17255742
Cited by
-
Longitudinal trajectories of weight changes among people living with HIV on antiretroviral therapy: A group-based study.iScience. 2023 Oct 20;26(11):108259. doi: 10.1016/j.isci.2023.108259. eCollection 2023 Nov 17. iScience. 2023. PMID: 38026178 Free PMC article.
-
Effect of dolutegravir-based first-line antiretroviral therapy on weight and body mass index among adult people living with HIV on follow up at health facilities in Hawassa city administration, Southern Ethiopia: a retrospective cohort study.Ann Med. 2023;55(2):2242250. doi: 10.1080/07853890.2023.2242250. Ann Med. 2023. PMID: 37531412 Free PMC article.
-
Association Between Body Mass Index Variation and Early Mortality Among 834 Ethiopian Adults Living with HIV on ART: A Joint Modelling Approach.Infect Dis Ther. 2023 Jan;12(1):227-244. doi: 10.1007/s40121-022-00726-5. Epub 2022 Nov 28. Infect Dis Ther. 2023. PMID: 36443546 Free PMC article.
-
Effects of different integrase strand transfer inhibitors on body weight in patients with HIV/AIDS: a network meta-analysis.BMC Infect Dis. 2022 Feb 3;22(1):118. doi: 10.1186/s12879-022-07091-1. BMC Infect Dis. 2022. PMID: 35114968 Free PMC article.
-
Weight change after antiretroviral therapy initiation among adults living with HIV in Northwest Ethiopia: a longitudinal data analysis.BMJ Open. 2022 Feb 1;12(2):e055266. doi: 10.1136/bmjopen-2021-055266. BMJ Open. 2022. PMID: 35105589 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical